Record NNP B-NP O
date NN I-NP O
: : O O
2089-10-20 CD O B-DATE
Iorio NNP B-NP B-PATIENT
9290228 CD I-NP B-MEDICALRECORD
RENAL NNP B-NP O
FELLOW NNP I-NP O
CONSULT NNP I-NP O
H NNP I-NP O
&amp; . I-NP O
P NNP I-NP O
CC NNP B-NP O
: : O O
SOB NNP O O
HPI NNP B-NP O
: : O O
32 CD B-NP B-AGE
yo NNP I-NP O
WF NNP I-NP O
w/ VBD B-VP O
h/o VBN I-VP O
2 CD B-NP O
prior RB I-NP O
failed VBN I-NP O
kidney NN I-NP O
transplants NNS I-NP O
and CC O O
now RB B-VP O
w/ VB I-VP O
a DT B-NP O
functioning NN I-NP O
DDKT NNP I-NP O
placed VBD B-VP O
on IN B-PP O
6/16/89 CD B-NP B-DATE
, , O O
a DT B-NP O
h/o NN I-NP O
SVC NNP I-NP O
syndrome NN I-NP O
requiring VBG B-VP O
angioplasty JJ B-NP O
and CC I-NP O
declotting VBG I-NP O
and CC I-NP O
HTN NNP I-NP O
presents VBZ B-VP O
w/ PRP B-NP O
acute JJ B-NP O
onset NN I-NP O
of IN B-PP O
SOB. NNP B-NP O
She PRP B-NP O
says VBZ B-VP O
she PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
LE JJ B-NP O
edema NN I-NP O
X NNP B-NP O
one CD I-NP O
month NN I-NP O
that WDT B-NP O
started VBD B-VP O
in IN B-PP O
the DT B-NP O
RLE NNP I-NP O
and CC O O
then RB O O
became VBD B-VP O
bilateral JJ B-ADJP O
. . O O
She PRP B-NP O
was VBD B-VP O
started VBN I-VP O
on IN B-PP O
lasix NN B-NP O
20 CD I-NP O
mg NN I-NP O
po NN I-NP O
qd NN I-NP O
. . O O
The DT B-NP O
swelling VBG I-NP O
has VBZ B-VP O
not RB I-VP O
resolved VBN I-VP O
. . O O
She PRP B-NP O
then RB B-ADVP O
describes VBZ B-VP O
abdominal NN B-NP O
fullness/bloating VBG B-VP O
yesterday NN B-NP O
and CC O O
sudden JJ B-NP O
onset NN I-NP O
of IN B-PP O
SOB NNP B-NP O
last JJ B-NP O
night NN I-NP O
while IN B-SBAR O
getting VBG B-VP O
ready JJ B-ADJP O
to TO B-VP O
go VB I-VP O
to TO B-PP O
bed NN B-NP O
. . O O
When WRB B-ADVP O
she PRP B-NP O
woke VBD B-VP O
up RP I-VP O
earlier JJR B-NP O
today NN I-NP O
she PRP B-NP O
still RB B-ADVP O
felt VBD B-VP O
SOB NNP B-NP O
and CC O O
came VBD B-VP O
to TO B-PP O
the DT B-NP O
ED. NNP I-NP O
She PRP B-NP O
denies VBZ B-VP O
PND NNP B-NP O
or CC I-NP O
orthopnea NNP I-NP O
. . O O
She PRP B-NP O
denies VBZ B-VP O
chest NN B-NP O
pain NN I-NP O
. . O O
Her PRP$ B-NP O
initial JJ I-NP O
vitals NNS I-NP O
were VBD B-VP O
T NNP B-NP O
98.6 CD I-NP O
, , O O
BP NNP B-NP O
156/86 CD I-NP O
, , O O
HR NNP B-NP O
97 CD I-NP O
, , I-NP O
99 CD I-NP O
% NN I-NP O
RA. NN I-NP O
She PRP B-NP O
says VBZ B-VP O
her PRP$ B-NP O
BP&#8217 NN I-NP O
;s NNS I-NP O
at IN B-PP O
home NN B-NP O
were VBD B-VP O
in IN B-PP O
a DT B-NP O
decent JJ I-NP O
range NN I-NP O
( -LRB- O O
140&#8217 CD B-NP O
;s NN I-NP O
) -RRB- O O
but CC O O
didn&#8217;t JJ B-NP O
measure NN I-NP O
her PRP B-NP O
BP NNP B-VP O
since IN B-PP O
the DT B-NP O
onset NN I-NP O
of IN B-PP O
her PRP B-NP O
SOB. . O O
PMHX NNP B-NP O
: : O O
1 LS O O
. . B-NP O
MPGN NNP I-NP O
, , O O
LDKT NNP B-NP O
2070 CD I-NP B-DATE
and CC O O
2078 CD B-NP B-DATE
now RB I-NP O
with IN B-PP O
functioning VBG B-VP O
DDKT NNP B-NP O
6/16/88 CD I-NP B-DATE
2. DT B-NP O
HD NNP I-NP O
for IN B-PP O
several JJ B-NP O
years NNS I-NP O
with IN B-PP O
multiple JJ B-NP O
graft NN I-NP O
surgeries NNS I-NP O
3. DT B-NP O
Superior NNP I-NP O
vena NN I-NP O
cava NN I-NP O
syndrome NN I-NP O
requiring VBG B-VP O
angioplasty JJ B-NP O
and CC I-NP O
declotting VBG I-NP O
. . O O
4 CD B-LST O
. . O O
Seizures NNP B-NP O
( -LRB- I-NP O
remote NN I-NP O
) -RRB- O O
5 CD B-LST O
. . O O
Parathyroidectomy '' O O
6 CD B-LST O
. . O O
HTN '' O O
7. . B-NP O
Sytemic NNP I-NP O
nephrogenic JJ I-NP O
fibrosis NN I-NP O
8. DT B-NP O
h/o NN I-NP O
MSSA NNP I-NP O
bacteremia NN I-NP O
in IN B-PP O
2088 CD B-NP B-DATE
while IN I-NP O
on IN B-SBAR O
HD NNP B-NP O
ALL NNP B-NP O
: : O O
cipro NN B-NP O
, , O O
pcn NN B-NP O
( -LRB- I-NP O
rash NN I-NP O
) -RRB- I-NP O
, , I-NP O
vanco FW I-NP O
( -LRB- I-NP O
red JJ I-NP O
man&#8217 NN I-NP O
;s NN I-NP O
) -RRB- I-NP O
, , O O
quinolone RB O O
MEDS NNS B-NP O
: : O O
calcium NN B-NP O
carbonate NN I-NP O
and CC I-NP O
vitamin NN I-NP O
d VBD B-VP O
500mg/200units PRP$ B-NP O
po NN I-NP O
bid NN I-NP O
Cellcept IN B-PP O
750mg CD B-NP O
po NN I-NP O
bid NN I-NP O
Diovan NNP B-NP O
160mg CD I-NP O
po NN I-NP O
daily RB B-SBAR O
doxepin NN B-NP O
50mg JJ I-NP O
po NN I-NP O
at IN B-PP O
bedtime NN B-NP O
ferrous JJ B-NP O
gluconate NN I-NP O
Lasix NNP B-NP O
20mg CD I-NP O
po NN I-NP O
once RB B-SBAR O
a DT B-NP O
day NN I-NP O
metformin NN B-NP O
hydrochloride NN I-NP O
500mg JJ I-NP O
po NN I-NP O
bid NN I-NP O
Paxil NNP B-NP O
10mg CD I-NP O
po NN I-NP O
bid NN I-NP O
prednisone NN B-NP O
5mg JJ I-NP O
po NN I-NP O
daily RB O O
Prilosec NNP B-NP O
20mg CD I-NP O
po NN I-NP O
daily RB B-SBAR O
Prograf NNP B-NP O
4 CD I-NP O
mg NN I-NP O
bid NN I-NP O
sodium NN B-NP O
bicarbonate NN I-NP O
tablets NNS B-VP O
650 CD B-NP O
mg NN I-NP O
oral JJ B-NP O
twice RB I-NP O
a DT B-NP O
day NN I-NP O
Xanax NNP B-NP O
0.5mg CD I-NP O
po NN I-NP O
tid NN I-NP O
PRN . O O
Social JJ B-NP O
history NN I-NP O
: : O O
Occupation NNP B-NP O
:disabled CC O O
ETOH NNP B-NP O
History NNP I-NP O
:none NN I-NP O
Drug NNP B-NP O
History NNP I-NP O
:none NN I-NP O
Smoking VBG B-NP O
History NN I-NP O
: : O O
smoked VBN B-VP O
for IN B-PP O
6 CD B-NP O
mo NN I-NP O
when WRB B-ADVP O
she PRP B-NP O
was VBD B-VP O
17 CD B-NP B-AGE
yo CD I-NP O
PE NN B-NP O
: : O O
98.7 CD B-NP O
BP NNP I-NP O
193/100 CD I-NP O
HR NNP I-NP O
105 CD I-NP O
RR NNP I-NP O
20 CD I-NP O
BP NNP I-NP O
99 CD I-NP O
% NN I-NP O
RA NN I-NP O
GEN NNP B-NP O
: : O O
AA NNP B-NP O
, , O O
tachypnic VBG B-VP O
, , O O
anxious JJ B-NP O
, , I-NP O
cushinoid JJ I-NP O
fascial JJ I-NP O
features NNS I-NP O
. . O O
HEENT NNP B-NP O
: : O O
Face NN B-NP O
swollen VBN B-VP O
w/ IN B-PP O
periorbital NN B-NP O
edema NN I-NP O
NECK NNP B-NP O
: : O O
Couldn&#8217;t IN B-NP O
see VB B-VP O
jvd VBN I-VP O
. . O O
LUNGS NNP B-NP O
: : O O
diffuse JJ B-NP O
mild JJ I-NP O
rales NNS I-NP O
. . O O
Good JJ O O
air NN B-NP O
movement NN I-NP O
, , O O
no DT B-NP O
wheezes NNS I-NP O
. . O O
CV NNP B-NP O
: : O O
rrr NN B-NP O
, , O O
nl JJ B-NP O
s1 NN I-NP O
and CC I-NP O
s2 NN I-NP O
, , O O
no DT B-NP O
m/r/g NN I-NP O
ABD NNP B-NP O
: : O O
NABS NNP B-NP O
, , I-NP O
soft JJ I-NP O
, , I-NP O
nt JJ I-NP O
, , I-NP O
nd CC O O
EXT NNP B-NP O
: : O O
1+ CD B-NP O
BLE NN I-NP O
edema NN I-NP O
. . O O
LUE DT B-NP O
AVF NN I-NP O
with IN B-PP O
excellent JJ B-NP O
thrill NN I-NP O
and CC O O
bruit NN B-NP O
LABS NNP B-NP O
:Na NNP I-NP O
140 CD I-NP O
K NNP I-NP O
4.9 CD I-NP O
Cl NNP B-NP O
107 CD I-NP O
HCO3 IN B-PP O
23 CD B-NP O
BUN NNP I-NP O
37 CD I-NP O
Cr NNP I-NP O
1.51 CD I-NP O
Glu NNP I-NP O
130 CD I-NP O
AG NNP I-NP O
10 CD I-NP O
Ca MD O O
9.9 CD B-NP O
Phos JJ I-NP O
3.7 CD I-NP O
Mg JJ I-NP O
1.9 CD I-NP O
LFTS NNS I-NP O
WNL NNP B-NP O
Alb NNP I-NP O
4.3 CD O O
WBC NNP B-NP O
9.0 CD I-NP O
Hgb NN I-NP O
8.8 CD I-NP O
HCT NNP I-NP O
26.9 CD I-NP O
PLTS NNP I-NP O
361 CD I-NP O
MCV NNP I-NP O
101 CD I-NP O
UA NNP B-NP O
2+ JJ I-NP O
protein NN I-NP O
, , O O
1+blood JJ B-NP O
, , I-NP O
neg JJ I-NP O
nit NN I-NP O
, , O O
neg JJ B-NP O
LE JJ I-NP O
, , I-NP O
SG NNP I-NP O
1.015 CD I-NP O
CXR NN B-NP O
: : O O
Mild NNP B-NP O
hilar NN I-NP O
fullness IN B-PP O
R&gt;L NNP B-NP O
. . O O
No DT B-NP O
pleural JJ I-NP O
effusions NNS I-NP O
. . O O
LAVF NNP B-NP O
duplex NN I-NP O
: : O O
no DT B-NP O
stenosis NN I-NP O
or CC I-NP O
thrombosis NN I-NP O
KUB NNP B-NP O
Negative NNP I-NP O
ECHO NNP B-NP O
: : O O
EF NNP B-NP O
77 CD I-NP O
% NN I-NP O
, , O O
RVSP NNP B-NP O
96 CD I-NP O
( -LRB- O O
was VBD B-VP O
40 CD B-NP O
in IN B-PP O
2/4/88 CD B-NP B-DATE
) -RRB- I-NP O
, , I-NP O
Normal JJ I-NP O
RV NN I-NP O
FCT . O O
1/88 CD B-NP B-DATE
25vitD CD I-NP O
9 CD O O
12/88 CD B-NP B-DATE
Uprot/Ucr NNP I-NP O
333 CD I-NP O
A/P NNP B-NP O
) -RRB- O O
SOB NNP B-NP O
: : O O
Very RB B-ADVP O
high JJ B-NP O
pulm NN I-NP O
pressures NNS I-NP O
with IN B-PP O
dilated JJ B-NP O
pulmonary NN I-NP O
arteries NNS I-NP O
especially RB B-ADVP O
in IN B-PP O
comparison NN B-NP O
to TO B-PP O
prior JJ B-NP O
echos NNS I-NP O
in IN B-PP O
the DT B-NP O
setting NN I-NP O
of IN B-PP O
sudden JJ B-NP O
onset NN I-NP O
SOB NNP I-NP O
and CC I-NP O
LE JJ I-NP O
edema NN I-NP O
in IN B-PP O
a DT B-NP O
patient NN I-NP O
who WP B-NP O
is VBZ B-VP O
sedentary JJ B-ADJP O
and CC O O
has VBZ B-VP O
had VBN I-VP O
thrombotic VBN I-VP O
events NNS B-NP O
in IN B-PP O
the DT B-NP O
past NN I-NP O
makes VBZ B-VP O
PE NN B-NP O
a DT B-NP O
likely JJ I-NP O
possibility NN I-NP O
. . O O
Her PRP$ B-VP O
poorly RB I-VP O
controlled VBN I-VP O
HTN NNP B-NP O
, , O O
LE JJ B-NP O
edema NN I-NP O
and CC O O
rales NNS B-NP O
make VB B-VP O
flash NN B-NP O
pulmonary NN I-NP O
edema NN B-VP O
another DT B-NP O
consideration NN I-NP O
. . O O
Despite IN B-PP O
her PRP$ B-NP O
lack NN I-NP O
of IN B-PP O
a DT B-NP O
significant JJ I-NP O
smoking NN I-NP O
history NN I-NP O
she PRP B-NP O
had VBD B-VP O
emphasematous JJ B-NP O
changes NNS I-NP O
on IN B-PP O
prior JJ B-NP O
chest NN I-NP O
CT NN I-NP O
scans NNS I-NP O
and CC O O
so RB B-ADVP O
could MD B-VP O
be VB I-VP O
at IN B-PP O
risk NN B-NP O
for IN B-PP O
a DT B-NP O
COPD NNP I-NP O
exacerbation NN I-NP O
but CC O O
she PRP B-NP O
had VBD B-VP O
good JJ B-NP O
air NN I-NP O
movement NN I-NP O
w/o NN I-NP O
wheezes NNS I-NP O
. . B-PP O
Her PRP$ B-NP O
face NN I-NP O
appears VBZ B-VP O
slightly RB B-ADJP O
swollen JJ I-ADJP O
and CC O O
she PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
SVC NNP B-NP O
syndrome NN I-NP O
in IN B-PP O
the DT B-NP O
past NN I-NP O
but CC O O
her PRP$ B-NP O
facial JJ I-NP O
swelling VBG I-NP O
is VBZ B-VP O
likely JJ B-ADJP O
related VBN B-VP O
to TO B-PP O
her PRP$ B-NP O
steroids NNS I-NP O
, , O O
she PRP B-NP O
has VBZ B-VP O
only RB B-NP O
mild JJ I-NP O
venous JJ I-NP O
distention NN I-NP O
on IN B-PP O
her PRP$ B-NP O
chest NN I-NP O
and CC O O
she PRP B-NP O
claims VBZ B-VP O
her PRP B-NP O
fascial JJ B-NP O
swelling VBG I-NP O
is VBZ B-VP O
not RB O O
worse JJR B-ADJP O
then RB I-ADJP O
usual JJ I-ADJP O
. . O O
&# NN B-NP O
224;Agree CD I-NP O
w/ NN I-NP O
lasix NN I-NP O
60 CD B-NP O
mg NN I-NP O
iv NN I-NP O
BID NNP I-NP O
( -LRB- I-NP O
but CC I-NP O
pt NN I-NP O
may MD B-VP O
be VB I-VP O
preload JJ B-NP O
dependent JJ I-NP O
w/ NNS I-NP O
such JJ B-NP O
severe JJ I-NP O
pulm NN I-NP O
htn NN I-NP O
so IN B-SBAR O
we PRP B-NP O
have VBP B-VP O
to TO I-VP O
avoid VB I-VP O
volume NN B-NP O
depleting VBG B-VP O
her PRP B-NP O
) -RRB- O O
&# NN B-NP O
224;V/ CD I-NP O
Q NNP I-NP O
scan NN I-NP O
and CC I-NP O
LE JJ I-NP O
dopplers NNS I-NP O
&# NN B-NP O
224;If IN B-PP O
no DT B-NP O
PE NN I-NP O
and CC O O
not RB B-NP O
better JJR I-NP O
w/ NN I-NP O
lasix NN I-NP O
then RB B-ADVP O
will MD B-VP O
need VB I-VP O
to TO I-VP O
consider VB I-VP O
chest NN B-NP O
CT NN I-NP O
w/ IN B-PP O
IV NNP B-NP O
contrast NN I-NP O
to TO B-VP O
r/o VB I-VP O
SVC NNP B-NP O
syndrome NN I-NP O
and CC I-NP O
parechymal JJ I-NP O
lund NN I-NP O
problems NNS I-NP O
. . O O
&# RB B-NP O
224; CD I-NP O
When WRB I-NP O
pt VBN I-NP O
feeling NN I-NP O
better JJR O O
I PRP B-NP O
would MD B-VP O
check VB I-VP O
full JJ B-NP O
PFTS NNS I-NP O
to TO B-VP O
evaluate VB I-VP O
pulm NN B-NP O
htn NN I-NP O
and CC I-NP O
possibility NN I-NP O
of IN B-PP O
COPD. NNP B-NP O
I PRP B-NP O
would MD B-VP O
also RB I-VP O
screen VB I-VP O
her PRP B-NP O
for IN B-PP O
alpha-1-antitrypsin JJ B-NP O
deficiency NN I-NP O
given VBN B-VP O
the DT B-NP O
emphysematous JJ I-NP O
changes NNS I-NP O
on IN B-PP O
prior RB B-NP O
CT. . O O
RENAL JJ B-NP O
TX NNP I-NP O
: : O O
Cr NNP B-VP O
only RB B-ADVP O
mildly RB B-ADVP O
above IN B-PP O
baseline NN B-NP O
. . O O
Hopefully '' O O
won&#8217;t VBD B-VP O
worsen VB I-VP O
w/ JJ B-NP O
lasix NN I-NP O
. . O O
&# NNS B-NP O
224;check VBP B-VP O
prograf NN B-NP O
trough NN I-NP O
&# NNS B-NP O
224;continue VBP B-VP O
prograf NN B-NP O
, , I-NP O
cellcept NN I-NP O
, , I-NP O
prednisone NN I-NP O
at IN B-PP O
usual JJ B-NP O
doses NNS I-NP O
&# JJ B-NP O
224;given CD I-NP O
LE JJ I-NP O
edema NN I-NP O
check NN I-NP O
uprot/ucr RB B-NP O
ratio NN I-NP O
HTN NNP B-NP O
: : O O
Poorly NNP B-NP O
controlled VBD B-VP O
. . O O
It&#8217 PRP B-NP O
;s VBD B-VP O
partly RB I-VP O
worsenend VBN I-VP O
by IN B-PP O
her PRP$ B-NP O
anxiety NN I-NP O
. . O O
&# NN B-NP O
224;ativan JJ I-NP O
0.5 CD I-NP O
mg NN I-NP O
iv FW B-NP O
q FW I-NP O
8 CD I-NP O
hrs VBZ B-VP O
prn NN B-NP O
anxiety NN I-NP O
&# JJ B-NP O
224;Labetolol JJ I-NP O
20 CD I-NP O
mg NN I-NP O
IV NNP B-NP O
and CC O O
start VB B-VP O
labetolol VB I-VP O
100 CD B-NP O
mg JJ I-NP O
po NN I-NP O
bid NN I-NP O
( -LRB- B-VP O
bblocker JJR B-NP O
effect NN I-NP O
will MD B-VP O
slow VB I-VP O
HR NNP B-NP O
and CC O O
help VB B-VP O
flash VB I-VP O
pulm NN B-NP O
edema NN I-NP O
from IN B-PP O
diastolic JJ B-NP O
dyfct NN I-NP O
, , O O
the DT B-NP O
combined VBN I-NP O
alpha NN I-NP O
and CC O O
beta JJ B-NP O
blockade NN I-NP O
will MD B-VP O
give VB I-VP O
it PRP B-NP O
added VBD B-VP O
efficacy NN B-NP O
given VBN B-VP O
the DT B-NP O
severity NN I-NP O
of IN B-PP O
her PRP$ B-NP O
HTN NNP I-NP O
, , I-NP O
Norvasc NNP I-NP O
may MD B-VP O
not RB I-VP O
be VB I-VP O
ideal JJ B-NP O
given VBN B-VP O
her PRP$ B-NP O
LE JJ I-NP O
edema NN I-NP O
) -RRB- I-NP O
. . O O
? . O O
? . O O
?DM NNP B-NP O
: : O O
pt NN B-NP O
on IN B-PP O
metformin NN B-NP O
for IN B-PP O
&#8220;diabetes NNS B-NP O
prevention NN I-NP O
. . O O
&#8221 CD B-NP O
; : O O
Metformin NNP B-NP O
is VBZ B-VP O
contraindicated VBN I-VP O
for IN B-PP O
Cr NNP B-NP O
greater JJR I-NP O
then RB B-ADVP O
or CC O O
equal VB B-VP O
to TO B-PP O
1.4 CD B-NP O
in IN B-PP O
a DT B-NP O
female JJ I-NP O
pt NN I-NP O
. . O O
&# NN B-NP O
224;d/c CD I-NP O
metformin NN I-NP O
H/O NNP B-NP O
METABOLIC NNP I-NP O
ACIDOSIS NNP I-NP O
: : O O
Pt NNP B-NP O
on IN B-PP O
chronic NN B-NP O
bicarb NN I-NP O
likely JJ B-ADJP O
to TO B-PP O
her PRP$ B-NP O
baseline NN I-NP O
mild JJ I-NP O
allograft NN I-NP O
dysfct NN I-NP O
. . O O
This DT B-NP O
can MD B-VP O
be VB I-VP O
a DT B-NP O
sodium NN I-NP O
load NN I-NP O
that WDT B-NP O
can MD B-VP O
worsen VB I-VP O
her PRP$ B-NP O
pulm NN I-NP O
edema NN I-NP O
. . O O
&# NN B-NP O
224;d/c CD I-NP O
Na NNP I-NP O
bicarb NN I-NP O
Edwin NNP B-NP B-DOCTOR
Funk NNP I-NP I-DOCTOR
Renal NNP B-NP O
Fellow NNP I-NP O
